ClinicalTrials.gov
public full text
Public Domain
ASCEND: A Study of Cardiovascular Events iN Diabetes
cardiovascular-diseasediabetes-mellitusprimary-preventionrandomized-controlled-trialtype-1-diabetes-mellitustype-2-diabetes-mellitus
The purpose of this study is to determine whether 100mg daily aspirin versus placebo and/or supplementation with 1 gram daily omega-3 fatty acids or placebo prevents "serious vascular events" (i.e. non-fatal heart attack, non-fatal stroke or transient ischaemic attack, or death from vascular causes) in patients with diabetes who are not known to have occlusive arterial disease and to assess the effects on serious bleeding or other adverse events.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II#1102379
- The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis#874435
- Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients#858146
- CHOlesterol Lowering and Residual Risk in Type 2 Diabetes#876027
- Effects of Acipimox on Mitochondrial Function in Obesity#1164081
Record · ID 969771
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive